Advances in quinoxaline derivatives: synthetic routes and antiviral efficacy against respiratory pathogens
RSC Advances · 2024 · 14 (48) · 35400-35423
DOI: 10.1039/d4ra04292a ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Advances, 2024. Verfasst von Fateme Dehnavi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences Research Center, Department of Medicinal Chemistry, Mazandaran University of Medical Sciences Sari Iran abekhradnia@gmail.com…. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
3D lung visualization showing COVID-19 infection areas alongside respiratory pathogens. The antiviral drug structure and comparison of healthy vs. infected lungs demonstrate how the drug could restore lung health.
Autor:innen und Institutionen
- Pharmaceutical Sciences Research Center, Department of Medicinal Chemistry, Mazandaran University of Medical Sciences Sari Iran abekhradnia@gmail.com abekhradnia@mazums.ac.ir.
ORCID-Profile: Malihe Akhavan
Zitieren
APA
Dehnavi, F., Akhavan, M., & Bekhradnia, A. (2024). Advances in quinoxaline derivatives: synthetic routes and antiviral efficacy against respiratory pathogens. RSC Advances, 14(48), 35400-35423. https://doi.org/10.1039/d4ra04292a
Vancouver
Dehnavi F, Akhavan M, Bekhradnia A. Advances in quinoxaline derivatives: synthetic routes and antiviral efficacy against respiratory pathogens. RSC Advances. 2024;14(48):35400-35423. doi:10.1039/d4ra04292a
BibTeX
@article{Dehnavi2024,
author = {Dehnavi, Fateme and Akhavan, Malihe and Bekhradnia, Ahmadreza},
title = {Advances in quinoxaline derivatives: synthetic routes and antiviral efficacy against respiratory pathogens},
journal = {RSC Advances},
year = {2024},
volume = {14},
number = {48},
pages = {35400--35423},
doi = {10.1039/d4ra04292a}
}
EUVIMED